FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, Aug 18, 2022
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on August 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- QuVa Pharma, Inc.
- Inspection Date
- August 18, 2022
- Product Type
- Drugs
View Company Profile
ID · 97908c4c-919d-41af-bcef-d54cbf973a9b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1177937
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)(3)Acceptance of drug products
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of QuVa Pharma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 4, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| October 28, 2024 | VAI | Dallas District Office | Drug Quality Assurance |
| April 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.